Fundraising Fox

Aperture Bio

Techstars '23

Allston, US · Founded 2022 · Delaware corporation · 1 known investors

aperture.bio

Aperture Bio develops technologies to translate human tumor biology in order to reduce risk in preclinical drug development.

AI & Machine LearningBiotechHealthtech

Founders & leadership

LK
Laura KelleyNamed on SEC filing
HP
Hannah PetersonNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$120K disclosed across 2 rounds · 2023

$100KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura KelleyExecutive Officer, Director
  • Hannah PetersonExecutive Officer, Director
Offering amount
$100K
Amount sold
$100K
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura KelleyExecutive Officer, Director
  • Hannah PetersonExecutive Officer, Director
Offering amount
$20K
Amount sold
$20K
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Aperture Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aperture Bio do?
Aperture Bio develops technologies to translate human tumor biology in order to reduce risk in preclinical drug development.
Who are Aperture Bio's investors?
Aperture Bio's investors include Techstars.
How much funding has Aperture Bio raised?
Aperture Bio has disclosed $120K raised across 2 rounds.
Where is Aperture Bio headquartered?
Aperture Bio is headquartered in Allston, US.